Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

New treatments for male hypogonadism are effective and should be personalized.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Different hair removal methods have pros and cons, and more evidence is needed to prove laser treatments work.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.